Scarica l'app Stockscreener
0.4788
2.26%
0.0106
Dopo l'orario di chiusura:
.49
0.0112
+2.34%
Precedente Chiudi:
$0.4682
Aprire:
$0.4702
Volume 24 ore:
768.45K
Relative Volume:
0.82
Capitalizzazione di mercato:
$41.36M
Reddito:
$2.24M
Utile/perdita netta:
$-136.67M
Rapporto P/E:
-0.2091
EPS:
-2.29
Flusso di cassa netto:
$-102.08M
1 W Prestazione:
-4.26%
1M Prestazione:
-15.24%
6M Prestazione:
-20.87%
1 anno Prestazione:
-69.89%
Intervallo 1D:
$0.4613
$0.484
Intervallo di 1 settimana:
$0.4613
$0.5175
Portata 52W:
$0.3418
$1.8599
Century Therapeutics Inc Stock (IPSC) Company Profile
Nome
Century Therapeutics Inc
Settore
Industria
Telefono
215-981-4000
Indirizzo
25 N 38TH STREET, 11TH FLOOR, PHILADELPHIA
Confronta IPSC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IPSC
Century Therapeutics Inc
|
0.4788 | 41.10M | 2.24M | -136.67M | -102.08M | -2.29 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Century Therapeutics Inc Stock (IPSC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-08 | Iniziato | Rodman & Renshaw | Buy |
| 2023-08-28 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-12-27 | Iniziato | Chardan Capital Markets | Buy |
| 2022-10-31 | Iniziato | Guggenheim | Buy |
| 2022-10-10 | Iniziato | Canaccord Genuity | Buy |
| 2022-05-23 | Iniziato | H.C. Wainwright | Buy |
| 2022-05-12 | Iniziato | William Blair | Mkt Perform |
| 2021-07-13 | Iniziato | BofA Securities | Buy |
| 2021-07-13 | Iniziato | JP Morgan | Overweight |
| 2021-07-13 | Iniziato | Piper Sandler | Overweight |
Mostra tutto
Century Therapeutics Inc Borsa (IPSC) Ultime notizie
Is Century Therapeutics Inc. stock bottoming outPortfolio Profit Report & Free Community Consensus Stock Picks - Newser
Detecting price anomalies in Century Therapeutics Inc. with AIJuly 2025 Intraday Action & Community Consensus Trade Alerts - Newser
Understanding Century Therapeutics Inc.’s price movementTrade Analysis Summary & Real-Time Buy Zone Alerts - Newser
Century Therapeutics shares rise 1.89% premarket after Fractyl Health expands its board of directors. - AInvest
Can Century Therapeutics Inc. rally from current levels2025 Year in Review & Stepwise Trade Signal Guides - Newser
What high frequency data says about Century Therapeutics Inc.July 2025 Trade Ideas & Technical Entry and Exit Alerts - Newser
Applying Elliott Wave Theory to Century Therapeutics Inc.Portfolio Update Summary & Advanced Swing Trade Entry Plans - Newser
Using fundamentals and technicals on Century Therapeutics Inc.Earnings Risk Report & Safe Entry Zone Identification - Newser
Is Century Therapeutics Inc. showing insider buyingJuly 2025 Highlights & Weekly High Return Opportunities - khodrobank.com
What earnings revisions data tells us about Century Therapeutics Inc.Weekly Earnings Recap & AI Powered Buy/Sell Recommendations - Newser
Reversal indicators forming on Century Therapeutics Inc. stockEarnings Trend Report & Capital Efficient Trade Techniques - Newser
Using portfolio simulators with Century Therapeutics Inc. includedJuly 2025 Snapshot & AI Powered Trade Plan Recommendations - Newser
Analyzing Century Therapeutics Inc. with risk reward ratio chartsWeekly Profit Report & Growth Focused Entry Reports - Newser
How hedge fund analytics apply to Century Therapeutics Inc. stockProfit Target & Fast Gain Swing Trade Alerts - Newser
Price action breakdown for Century Therapeutics Inc.July 2025 Summary & Community Verified Swing Trade Signals - Newser
How moving averages guide Century Therapeutics Inc. tradingWeekly Investment Summary & Free High Return Stock Watch Alerts - Newser
Will Century Therapeutics Inc. outperform tech stocksDip Buying & AI Optimized Trading Strategy Guides - khodrobank.com
Is Century Therapeutics Inc. undervalued by DCF analysis2025 Year in Review & Verified Technical Signals - khodrobank.com
Century Therapeutics Inc. Added to Custom Quant Screener Today getLinesFromResByArray error: size == 0 - kangso.co.kr
Can Century Therapeutics Inc. expand its profit marginsEarnings Recap Report & Precise Trade Entry Recommendations - khodrobank.com
Using Ichimoku Cloud for Century Therapeutics Inc. technicalsMarket Movement Recap & Risk Controlled Stock Alerts - Newser
Earnings visualization tools for Century Therapeutics Inc.Weekly Gains Summary & Weekly Breakout Stock Alerts - Newser
What makes Century Therapeutics Inc. stock price move sharply2025 Technical Patterns & Risk Managed Investment Signals - Newser
Technical analysis overview for Century Therapeutics Inc. stockJuly 2025 Technicals & Smart Allocation Stock Tips - Newser
Is a relief rally coming for Century Therapeutics Inc. holdersTrade Signal Summary & Low Risk Entry Point Guides - Newser
What data driven models say about Century Therapeutics Inc.’s futureQuarterly Market Review & Consistent Profit Trading Strategies - Newser
Century Therapeutics Granted Nasdaq Compliance Extension - TipRanks
Regression Model Predicts Rangebound Movement in Century Therapeutics Inc.Portfolio Value Summary & Weekly High Return Stock Forecasts - beatles.ru
Using Bollinger Bands to evaluate Century Therapeutics Inc.2025 Historical Comparison & AI Powered Buy and Sell Recommendations - Newser
Layoff Tracker: Exelixis Cuts Go Beyond Pennsylvania, Include 71 at California HQ - BioSpace
Century Therapeutics Inc Azioni (IPSC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Century Therapeutics Inc Azioni (IPSC) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Carr Douglas | SVP Finance & Operations |
Aug 04 '25 |
Sale |
0.53 |
296 |
158 |
405,686 |
| Carr Douglas | SVP Finance & Operations |
Jun 09 '25 |
Sale |
0.62 |
4,904 |
3,050 |
405,982 |
| Farid Adrienne | Chief Operations Officer |
Jun 09 '25 |
Sale |
0.62 |
552 |
343 |
250,141 |
| Pfeiffenberger Brent | President and CEO |
Jun 09 '25 |
Sale |
0.62 |
475 |
295 |
1,681,783 |
| Russotti Gregory | See Remarks |
Jun 09 '25 |
Sale |
0.62 |
526 |
327 |
392,047 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):